[1] 任妙贤,陈良柱,潘志坤,等.头孢维星研究概况[J].动物医学进展,2015,36(2):106-110. REN M X,CHEN L Z,PAN Z K,et al.Research progress on cefovecin[J].Progress in Veterinary Medicine, 2015,36(2):106-110.(in Chinese)
[2] 李洁云,顾觉奋.5代头孢菌素类抗生素的研究进展和市场动态[J].药学进展,2014,38(8):741-746. LI J Y,GU J F.Research progress and market trend of the fifth generation cephalosporin antibiotics[J].Progress in Pharmaceutical Sciences,2014,38(8):741-746.(in Chinese)
[3] CAPRILE K A.The cephalosporin antimicrobial agents:A comprehensive review[J].Journal Veterinary Pharmacology and Therapeutics,1988,11(1):1-32.
[4] WORTHINGTON R J,MELANDER C.Overcoming resistance to β-lactam antibiotics[J].Journal of Organic Chemistry,2013,78(9):4207-4213.
[5] BRADLEY A J,BREEN J E,PAYNE B,et al.The use of a cephalonium containing dry cow therapy and an internal teat sealant,both alone and in combina-tion[J].Journal of Dairy Science,2010,93(4):1566-1577.
[6] VASQUEZ A K,NYDAM D V,CAPEL M B,et al.Randomized noninferiority trial comparing 2 commercial intramammary antibiotics for the treatment of nonsevere clinical mastitis in dairy cows[J].Journal of Dairy Science,2016,99(10):8267-8281.
[7] PALAMARA J D,BONCZYNSKI J J,BERG J M,et al.Perioperative cefovecin to reduce the incidence of urinary tract infection in dogs undergoing hemilaminectomy[J].The Journal of the American Animal Hospital Association,2016,52(5):297-304.
[8] PAPICH M G, DAVIS J L,FLOERCHINGER A M.Pharmacokinetics, protein binding, and tissue distribution of orally administered cefpodoxime proxetil and cephalexin in dogs[J].American Journal of Veterinary Research,2010,71(12):1484-1491.
[9] SONG I B,KIM T W,LEE H G,et al.Influence of the injection site on the pharmacokinetics of cefquinome following intramuscular injection in piglets[J].The Japanese Society of Veterinary Science,2013, 75(1):89-92.
[10] SWINKELS J M,COX P,SCHUKKEN Y H, et al.Efficacy of extended cefquinome treatment of clinical Staphylococcus aureus mastitis[J].Journal of Dairy Science,2013,96(8):4983-4992.
[11] MONTESISSA C,VILLA R,ANFOSSI P,et al.Pharmacodynamics and pharmacokinetics of cefoperazone and cefamandole in dogs following single dose intravenous and intramuscular administration[J].The Veterinary Journal,2003,166(2):170-176.
[12] STEVEN W, EBERHARD R.Cephalothin and cefazolin in vitro antibacterial activity and pharmacokinetics in dogs[J].Veterinary Surgery, 1995, 24:347-351.
[13] NIE H, FEN G, PENG J, et al.Comparative pharmacokinetics of ceftiofur hydrochloride and ceftiofur sodium after administration to water buffalo (Bubalus bubalis)[J].American Journal of Veterinary Research,2016,77(6):646-652.
[14] WENTE N,ZOCHE G V,BEHR M,et al.Susceptibility to cephalosporins of bacteria causing intramammary infections in dairy cows with a high somatic cell count in Germany[J].Preventive Veterinary Medicine, 2016,131:146-151.
[15] CARLI S,ANFOSSI P,VILLA R,et al.Absorption kinetics and bioavailability of cephalexin in the dog after oral and intramuscular administration[J].Journal of Veterinary Pharmacology and Therapeutics, 1999,22(5):308-313.
[16] COURTIN F,CRAIGMILL L,WETZLICH S E,et al.Pharmacokinetics of ceftiofur and metabolites after single intravenous and intramuscular administration and multiple intramuscular administrations of ceftiofur sodium to dairy goats[J].Journal of Veterinary Pharmacology and Therapeutics,1997,20(5):368-373.
[17] THOMAS E,THOMAS V,WILHELM C.Antibacterial activity of cefquinome against equine bacterial pathogens[J].Veterinary Microbiology,2006,115(1-3):140-147.
[18] CHRIST W.Pharmacological properties of cephalosporins[J].Infection,1991,19(S5):224-252.
[19] AMBROS L,KREIL V,TARRAGONA L,et al.Comparative pharmacokinetics of intravenous cephalexin in pregnant,lactating,and non-pregnant,non-lactating goats[J].Journal of Veterinary Pharmacology and Therapeutics,2011,34(4):397-402.
[20] ALBARELLOS G A,MONTOYA L,PASSINI S M,et al.Cefazolin pharmacokinetics in cats under surgical conditions[J].Journal of Feline Medicine and Surgery,2017,19(10):992-997.
[21] ALBARELLOS G A,MONTOYA L,LORENZINI P M,et al.Pharmacokinetics of cefuroxime after intravenous, intramuscular,and subcutaneous administration to dogs[J].Journal of Veterinary Pharmacology and Therapeutics,2016,39(1):40-44.
[22] WARAICH G S,SIDHU P K, DAUNDKAR P S,et al.Pharmacokinetic and pharmacodynamic characterization of ceftiofur crystalline-free acid following subcutaneous administration in domestic goats[J].Journal of Veterinary Pharmacology and Therapeutics,2017,40(5):429-438.
[23] TAHA A,ASHRAF E,MOHAMED E,et al.Comparative pharmacokinetics of cefoperazone following intravenous and intramuscular administration in goats[J].International Journal of Veterinary Science and Medicine,2015,3:21-25.
[24] COX S,SOMMARDAHL C,SEDDIGHI R,et al.Pharmacokinetics of intravenous and subcutaneous cefovecin in alpacas[J].Journal of Veterinary Pharmacology and Therapeutics,2015,38(4):344-349.
[25] UNEY K,ALTAN F,EROL H,et al.Plasma and synovial fluid pharmacokinetics of cefquinome following the administration of multiple doses in horses[J].Journal of Veterinary Pharmacology and Therapeutics,2017,40(3):239-247.
[26] SHAN Q,ZHU X,LIU S,et al.Pharmacokinetics of cefquinome in tilapia (Oreochromis niloticus) after a single intramuscular or intraperitoneal administra-tion[J].Journal of Veterinary Pharmacology and Therapeutics,2015,38(6):601-605.
[27] WILBER R B,DOYLE C A,DURHAM S J,et al.Safety profile of cefprozil[J].Clinical Infectious Diseases, 1992,14(S2):264-271.
[28] SCATTLER F R,WEITEKAMP M R,BALLARD J O.Potential for bleeding with the new β-lactam antibiotics[J].Annals of Internal Medicine,1986,105(6):924-931.
[29] JAMES J L,JOHN C L,WILLIAM J.Production of hypoprothrombinemia by moxalactam and 1-methyl-5-thiotetrazole in rats[J].Antimicrobial Agents and Chemotherapy,1984,25(3):380-381.
[30] STEELE R W, BRADSHER R W.Comparison of ceftriaxone with standard therapy for bacterial meningitis[J].The Journal of Pediatrics,1983,103(1):138-141.
[31] COHEN M S,WASHTON H E,BARRANCO S F.Multicentre clinical trial of cefoperazone sodium in the United States[J].The American Journal of Medicine,1985,79(1):35-41.
[32] VIAL T,PONT J,PHAM E,et al.Cefaclor-associated serum sickness-like disease:Eight cases and review of the literature[J].Annals of Pharmacotherapy,1992,26(7-8):910-914.
[33] NEU H C.Third generation cephalosporins:Safety profiles after 10 years of clinical use[J].Journal of Clinical Pharmacology,1990,30(5):396-403.
[34] HOWARD S J,CATCHPOLE M,WATSON J,et al.Antibiotic resistance:Global response needed[J].The Lancet Infectious Disease,2013,13(12):1001-1003.
[35] RICHMOND M H.Factors influencing the antibacterial action of β-lactam antibiotics[J].Journal of Antimicrobial Chemotherapy,1978,4:1-14.
[36] HARTMAN B,TOMASZ A.Altered penicillin-binding proteins in methicillin-resistant strains of Staphylococcus aureus[J].Antimicrobial Agents and Chemotherapy,1981,19(5):726-735.
[37] JACKSON G G,LOLANS V T,GALLEGOS B G.Comparative activity of bacterial β-lactamases on penicillins and cephalosporins[J].The Journal of Infectious Diseases,1973,128:327-334.
[38] GIRLICH D,POIREL L CARATTOLI A,et al.Extended-spectrum β-lactamase CTX-M-1 in Escherichia coli isolates from healthy poultry in France[J].Applied and Environmental Microbiology,2007,73(14):4681-4685.
[39] JØRGENSEN C J,CAVACO L M,HASMAN H,et al.Occurrence of CTX-M-1-producing Escherichia coli in pigs treated with ceftiofur[J].Journal Antimicrobial Chemotherapy,2007,59(5):1040-1042.
[40] ARLET G,BARRETT T J,BUTAYE P,et al.Salmonella resistant to extended-spectrum cephalosporins:Prevalence and epidemiology[J].Microbes and Infection,2006,8(7):1945-1954.
[41] RIAÑO I,MORENO M A,TESHAGER T,et al.Detection and characterization of extended-spectrum β-lactamases in Salmonella enterica strains of healthy food animals in Spain[J].Journal of Antimicrobial Chemotherapy,2006,58(4):844-847.
[42] BRIÑAS L,MORENO M A,TESHAGER T,et al.Monitoring and characterization of extended-spectrum β-lactamases in Escherichia coli strains from healthy and sick animals in Spain in 2003[J].Antimicrobial Agents and Chemotherapy,2005,49(3):1262-1264.
[43] KOECK J L,ARLET G,PHILIPPON A,et al.A plasmid-mediated CMY-2β-lactamase from an Algerian clinical isolate of Salmonella senftenberg[J].FEMS Microbiology Letter,1997,152(2):255-260.
[44] ALCAINE S D,SUKHNANAND S S,WARNICK L D,et al.Ceftiofur-resistant Salmonella strains isolated from dairy farms represent multiple widely distributed subtypes that evolved by independent horizontal gene transfer[J].Antimicrobial Agents and Chemotherapy,2005,49(10):4061-4067.
[45] SMET A,MARTEL A,PERSOONS D,et al.Diversity of extended-spectrum β-lactamases and class C β-lactamases among cloacal Escherichia coli isolates in Belgian broiler farms[J].Antimicrobial Agents and Chemotherapy,2008,52(4):1238-1243.
[46] BOIREAU C,CAZEAU G,JARRIGE N,et al.Antimicrobial resistance trends in Escherichia coli isolated from diseased food-producing animals in France:A 14-year period time-series study[J].Zoonoses and Public Health,2017,65(1):86-94.
[47] TESHAGER T,DOMINGUEZ L,MORENO M A, et al.Isolation of an SHV-12β-lactamase-producing Escherichia coli strain from a dog with recurrent urinary tract infections[J].Antimicrobial Agents and Chemotherapy,2000,44(12):3483-3484.
[48] SHIRAKI Y,SHIBATA N,DOI Y,et al.Escherichia coli producing CTX-M-2β-lactamase in cattle,Japan[J].Emerging Infectious Diseases,2004,10(1):69-75.
[49] WEILL F X,LAILLER R,PRAUD K,et al.Emergence of extended-spectrum β-lactamase (CTX-M-9) -producing multiresistant strains of Salmonella enterica serotype virchow in poultry and humans in France[J].Journal of Clinical Microbiology,2004,42(12):5767-5773.
[50] POLITI L,TASSIOS T T,LAMBIRI M,et al.Repeated occurrence of diverse extended-spectrum β-lactamases in minor serotypes of food-borne Salmonella enterica subsp.Enterica[J].Journal Clinical Microbiology,2005,43(7):3453-3456.
[51] BERTRAND S,WEILL F X,VRINTS M,et al.Clonal emergence of extended-spectrum β-lactamase (CTX-M-2)-producing Salmonella enterica serovar virchow isolates with reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and France (2000 to 2003)[J].Journal of Clinical Microbiology,2006,44(8):2897-2903.
[52] HASMAN H,MEVIUS D,VELDMAN K,et al.β-lactamases among extended-spectrum β-lactamase (ESBL)-resistant Salmonella from poultry,poultry products and human patients in The Netherlands[J].Journal of Antimicrobial Chemotherapy,2005,56(1):115-121.
[53] CHEN S, ZHAO S H, WHITE D G,et al.Characterization of multiple-antimicrobial-resistant Salmonella serovars isolated from retail meats[J].Applied and Environmental Microbiology,2004,70(1):1-7.
[54] ARESTRUP F M,HASMAN H,OLSEN I,et al.International spread of blaCMY-2-mediated cephalosporin resistance in a multiresistant Salmonella enterica serovar heidelberg isolate stemming from the importation of a boar by denmark from Canada[J].Antimicrobial Agents and Chemotherapy,2004,48(5):1916-1917.
[55] BRADFORD P A,PETERSEN P J,FINGERMAN I M,et al.Characterization of expanded-spectrum cephalosporin resistance in E.coli isolates associated with bovine calf diarrhoeal disease[J].Journal of Antimicrobial Chemotherapy,1999,44(5):607-610.
[56] KOJIMA A,ISHⅡ Y,ISHIHARA K,et al.Extended-spectrum-β-lactamase-producing Escherichia coli strains isolated from farm animal from 1999 to 2002:Report from the Japanese veterinary antimicrobial resistance monitoring program[J].Antimicrobial Agents and Chemotherapy,2005,49(8):3533-3537.
[57] VO A T,DUIJKEREN E V,FLUIT A C,et al.Characteristics of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from horses[J].Veterinary Microbiology,2007, 124(3-4):248-255.
[58] EARNSHAW S,MENDEZ A,MONNET D L,et al.Global collaboration to encourage prudent antibiotic use[J].The Lancet Infectious Disease,2013,13(12):1003-1004.
[59] VOELKER R.FDA:Limited ban on cephalosporin use in major food-producing animals[J].Journal of the American Association,2012,307(5):443.
[60] AGERSOØ Y,AARESTRUP F M.Voluntary ban on cephalosporin use in Danish pig production has effectively reduced extended-spectrum cephalosporinase-producing Escherichia coli in slaughter pigs[J].Journal of Antimicrobial Chemotherapy,2013,68(3):569-572.
[61] DUTIL L,IRWIN R,FINLEY R,et al.Ceftiofur resistance in Salmonella enterica serovar Heidelberg from chicken meat and humans,Canada[J].Emerging Infectious Diseases,2010,16(1):48-54.
[62] 刘玉华,王琳琳,方向红,等.鸡源大肠杆菌超广谱β-内酰胺酶的检测及耐药性分析[J].中国畜牧兽医,2014,41(12):271-275. LIU Y H,WANG L L,FANG X H,et al.Detection and analysis of drug resistance of ESBLs in Escherichia coli strains isolated from chickens[J].China Animal Husbandry & Veterinary Medicine,2014,41(12):271-275.(in Chinese)
[63] 薛雨,陈宇瑛.头孢菌素类抗生素的最新研究进展[J].中国抗生素杂志,2011,36(2):86-92. XUE Y,CHEN Y Y.New development of cephalosporin antibiotics[J].Chinese Journal of Antibiotics,2011,36(2):86-92.(in Chinese) |